NerPharMa is a newly established company, operating since January 2010 and it was created as a spin-off from Nerviano Medical Sciences, the largest, privately owned R&D facility in Italy.

Nerviano site was originally established by Farmitalia Carlo Erba, one of the first companies to develop anticancer drugs and continued to be a center of excellence in this field.

Nerviano Medical Sciences spin off from Pfizer in 2004.

NerPharMa is divided into two sections NerPharMa DP (Drug Product ) and NerPharMa DS (Drug Substance).